Healio Rheumatology

CURRENTLY VIEWING:

The following articles appeared in the print edition of HEALIO RHEUMATOLOGY.

Table of Contents
By the Numbers

Five Important News Items in Pediatric Rheumatology

Cover Story

Managing Care and Cost in a Profit-driven System

Drug Pipeline

FDA Approves First Extended-release Injection to Treat Osteoarthritis Knee Pain

AbbVie and Amgen Announce Settlement of Adalimumab Patent Dispute

FDA Approves Shingles Vaccine Shingrix

Janssen Biotech Receives FDA Approval for Simponi Aria for the Treatment of Active PsA, AS

Janssen Biotech Will Not Pursue Global Approval for Sirukumab

Editorial

Rheumatology, Managed Care and Burnout

Leonard H. Calabrese, DO

Education Lab

Diagnosis and Treatment of Pemphigus Vulgaris: Strategies for Optimal Multidisciplinary Care

Guest Editorial

Treatment of Giant Cell Arteritis With Tocilizumab: A Historical Perspective

Gary S. Hoffman, MD, MS, MACR

Guidelines

Multidisciplinary Task Force Releases Consensus Document on Biosimilars

In the Journals

Patients Treated With Febuxostat for Early Gout Had Lower Overall Rate of Flares

Women on Biologics are Likely to Halt These Drugs Once Pregnant

RA Characteristics Responsible for Roughly 30% of CVD Events

Secukinumab Yielded Improvements for PsA Through 2 Years

Fatigue, Including Stress, Cited Among the Most Common Triggers of Oral Ulcers for Behcet’s Disease

Communication-and-resolution Programs May Avert Lawsuits From Medical Errors

Extent of Disease Damage Cited as Factor for Higher Mortality Among Impoverished Patients With SLE

Intra-articular Corticosteroid Injections Seen as Efficacious for Short-term Management of Knee OA

Profile

Association of Women in Rheumatology: Promoting Mentorship, Inclusivity

Q&A With Healio Rheumatology

Juvenile Arthritis: Treatment is Now a More ‘Optimistic Story’

Trend Watch

Medically Injured Patients Desire to Know More About Prevention Efforts

California Law May Minimally Impact Drug Pricing Transparency

Disability Prevention Program Lessened Work Loss Due to Rheumatic, Musculoskeletal Conditions

Advertisement
Advertisement